Rxo (RXO) Enterprise Value (2021 - 2025)
Rxo (RXO) has disclosed Enterprise Value for 5 consecutive years, with -$17.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 51.43% year-over-year to -$17.0 million, compared with a TTM value of -$17.0 million through Dec 2025, up 51.43%, and an annual FY2025 reading of -$17.0 million, up 51.43% over the prior year.
- Enterprise Value was -$17.0 million for Q4 2025 at Rxo, up from -$25.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$5.0 million in Q4 2023 and bottomed at -$187.0 million in Q3 2022.
- Average Enterprise Value over 5 years is -$56.5 million, with a median of -$29.0 million recorded in 2021.
- The sharpest move saw Enterprise Value skyrocketed 94.9% in 2023, then crashed 600.0% in 2024.
- Year by year, Enterprise Value stood at -$29.0 million in 2021, then crashed by 237.93% to -$98.0 million in 2022, then surged by 94.9% to -$5.0 million in 2023, then plummeted by 600.0% to -$35.0 million in 2024, then surged by 51.43% to -$17.0 million in 2025.
- Business Quant data shows Enterprise Value for RXO at -$17.0 million in Q4 2025, -$25.0 million in Q3 2025, and -$18.0 million in Q2 2025.